Newsroom | 12785 results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/768174807 To l...

MELBOURNE, Australia--(BUSINESS WIRE)--TLC Healthcare (TLC) - a leading healthcare provider of multi-generational healthcare across Victoria, Australia - announced today that it has engaged Mayo Clinic Global Consulting to provide advisory services related to TLC’s integrated care expansion with the launch of its new Hospital Day Surgery in Hallam, Victoria. Under the advisory contract, Mayo Clinic experts will provide advisory services to TLC for its Hospital Day Surgery, including facility an...

NEWARK, Calif.--(BUSINESS WIRE)--Aztron Medtech receives Taiwan's Presidential Award and NT$10 million grand prize, accelerating U.S. expansion and orthopedic innovation....

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene (intismeran; V940 or mRNA-4157), a novel investigational mRNA-based individualized neoantigen therapy (INT) being jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck’s a...

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the second quarter ended June 30, 2026 (“Second quarter 2026” or “2Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 2Q’26 Consolidated Highligh...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--UNC Health Launches UNC Health Ventures...

PITTSBURGH--(BUSINESS WIRE)--Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device businesses, including successful launches of robotic technology platforms and one of the industry’s most advanced knee systems, lends significant value to Peptilogics as it moves towards bringing meaningful innovation t...

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI reported financial results for three months ended June 30, 2026, as well as key recent corporate and clinical developments for Multikine....

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the second quarter of 2026 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.4 million and an operating loss of $5.1 million. For the first half of the year, net sales were $14.4 million and operating losses were $11.3 million as compared to 2025 net revenues of $18.7 million and operating loss...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a developer of surgical technologies for spine and orthopedic procedures, today announced that it has been named to the 2026 Inc. 5000, the annual list of the fastest-growing private companies in America. The prestigious list recognizes companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2...